Get started
Author

Murat Ayhan

The real‐world outcomes of Lutetium‐177 PSMA‐617 radioligand therapy in metastatic castration‐resistant prostate cancer: Turkish Oncology Group multicenter study
2023 · Elvina Almuradova, Mustafa Seyyar, et al. · International Journal of Cancer · 30
Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study
2021 · Seher Yildiz Tacar, Fatih Selcukbiricik, et al. · Melanoma Research · 20
Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience
2021 · Murat Ayhan, Hatice Odabas, et al. · Journal of Chemotherapy · 13
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
2021 · Murat Ayhan, Şahin Laçin, et al. · Journal of Oncology Pharmacy Practice · 11
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma
2024 · Haci Arak, Suna Erkiliç, et al. · Journal of Immunotherapy · 7
HALP Score as a New Prognostic Factor for Patients with Metastatic Bladder Cancer
2023 · Omer Acar, Murat Ayhan, et al. · Journal of College of Physicians And Surgeons Pakistan · 7
PDF
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
2021 · Burak Bilgin, Mehmet Ali Nahit Sendur, et al. · Journal of Cancer Research and Clinical Oncology · 6
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
2022 · Mutlu Hizal, Burak Bilgin, et al. · Journal of Cancer Research and Clinical Oncology · 5
PDF
Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin
2021 · Melike Ozcelik, Abdlkerim Oyman, et al. · Journal of College of Physicians And Surgeons Pakistan · 5
PDF
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
2021 · Ibrahim Cil, Ahmet Kucukarda, et al. · Tumori Journal · 5
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study
2022 · Izzet Dogan, Murat Ayhan, et al. · Medicine · 4
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
2022 · Özlem Özdemir, Baha Zengel, et al. · Anti-Cancer Drugs · 4
Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis?
2021 · Kadriye Terzioğlu, Murat Ayhan · Journal of Oncology Pharmacy Practice · 4
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
2021 · Mutlu Hizal, Burak Bilgin, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
2022 · Mutlu Hizal, Burak Bilgin, et al. · Future Oncology · 3
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
2022 · Özgecan Dülgar, Başak Bala Öven, et al. · Expert Review of Anticancer Therapy · 3
Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer
2021 · Atakan Topcu, Muhammed Mustafa Atci, et al. · Future Oncology · 3
Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?
2020 · Murat Ayhan, Nedim Turan, et al. · Current Problems in Cancer · 3
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study
2025 · Zehra Sucuoğlu İşleyen, Seval Ay, et al. · Scientific Reports · 2
PDF
Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer
2024 · Cengiz Karacin, Veli Sunar, et al. · Future Oncology · 2
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
2024 · Osman Köstek, Ahmet Demirel, et al. · Journal of Chemotherapy · 2
Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens
2023 · Rukiye Arikan, Muhammed Atci, et al. · Oncology Letters · 2
PDF
Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?
2021 · Esra Özyurt, Serhat Özçelik, et al. · Journal of Oncology Pharmacy Practice · 2
Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group
2021 · Baran Akagündüz, Tuğba Akın Telli, et al. · Van Yüzüncü Yıl University Academic Data Management System · 2
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study
2025 · Alpaslan Ozgun, Fatma Mustafayev, et al. · Molecular and Clinical Oncology · 1
PDF
Works count: 43
Citation count: 154
H-index: 6
I10-index: 4
Year
Topic
Type